Thorne HealthTech, Inc. (NASDAQ:THRN) Q4 2022 Earnings Conference Call March 31, 2023 8:00 AM ET
Company Participants
Thomas Wilson – Vice President-Investor Relations
Paul Jacobson – Chief Executive Officer
Michelle Crow – Chief Medical Officer
Tom McKenna – Chief Operating Officer
Conference Call Participants
Elizabeth Anderson – Evercore
Susan Anderson – Canaccord Genuity
Steven Mah – Cowen
Operator
Hello everyone, and welcome to the Thorne HealthTech Fourth Quarter 2022 Earnings Call. My name is Charlie and I'll be coordinating the call today. You'll have the opportunity to ask a question at the end of the presentation. [Operator Instructions]
I will now hand over to our host, Thomas Wilson, VP of Investor Relations to begin. Thomas, please go ahead.
Thomas Wilson
Good morning, everyone. Thank you for joining Thorne HealthTech’s fourth quarter and full year 2022 earnings call. With me today are Paul Jacobson, our CEO; Tom McKenna, our COO; Michelle Crow, our CMO and Ann Blake, our Corporate Controller, who's available for questions. In addition, Saloni Varma, our new CFO, who we are delighted to have joining next week is also with us today.
Before we begin, please note that today's discussion contains forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those indicated by our forward-looking statements. More information about potential risk factors can be found in our 2021 Annual Report on Form 10-K, and our upcoming Form 10-K, which we anticipate filing after market today and in other SEC filings.
Today in addition to U.S. GAAP reporting, we will be discussing financial measures that do not conform to GAAP. We believe these non-GAAP measures enhance the understanding of our performance because they are more representative of how we internally measure the business.
Non-GAAP financial measures should not be considered in isolation from or as a substitute for GAAP measures. A reconciliation of GAAP to non-GAAP results is available in the earnings press release we issued after market closed yesterday and in the supplemental investor presentation posted to our IR website.
With that, I'll turn the call over to Paul.
Paul Jacobson
Thank you, Thomas. Good morning. Thanks everyone for joining the call. Today, I'll discuss our full year and fourth quarter 2022 results, update you on the progress we've made against core growth strategies shared during the IPO process, provide our outlook for 2023, including financial targets for the year, I will also share a few comments related to our longer term positioning, including the expansion of our vertical operations with the new world-class facility that will add new capabilities and bring capacity online to fuel efficient long-term growth. As Thomas mentioned, additional details can be found in the earnings release and investor supplement issued after market close yesterday. With that, let's dive in.